ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dresdale, A.
Right arrow Articles by Rose, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dresdale, A.
Right arrow Articles by Rose, E. A.

The Annals of Thoracic Surgery, Vol 40, 385-387, Copyright © 1985 by The Society of Thoracic Surgeons


ARTICLES

Hemostatic effectiveness of fibrin glue derived from single-donor fresh frozen plasma

A Dresdale, FO Bowman Jr, JR Malm, K Reemtsma, CR Smith, HM Spotnitz and EA Rose

Fibrin glue derived from pooled human blood is an effective sealant for high-porosity vascular grafts and a valuable topical hemostatic agent in heparinized patients. Use of this agent in the United States is prohibited because of potential transmission of hepatitis B, acquired immunodeficiency syndrome, and other serologically transmitted illnesses. We have developed a cryoprecipitation technique that allows preparation of fibrin glue from single-donor fresh frozen plasma. Use of this agent presumably entails no greater risk of disease transmission than intravenous administration of single-unit fresh frozen plasma. This report describes our early clinical experience with this material. Fibrin glue was used as a sealant for porous woven Dacron tubular prostheses and cardiovascular patches in 19 patients. The fibrin glue sealant has also been employed to control bleeding from needle holes and small anastomotic tears in 22 patients. No patient in this series had a bleeding complication from a suture line or graft treated with fibrin glue. This experience indicates that like fibrin glue from pooled blood, fibrin glue from single-donor plasma is effective as a graft sealant and topical hemostatic agent. Preparation of fibrin glue from single-donor plasma is simple and economical, and may provide cardiothoracic surgeons in the United States with a widely available, valuable hemostatic adjunct.


This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
P. D. Mintz, L. Mayers, N. Avery, H. L. Flanagan, S. G. Burks, and W. D. Spotnitz
Fibrin Sealant: Clinical Use and the Development of the University of Virginia Tissue Adhesive Center
Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 108 - 118.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. C. Economopoulos, P. D. Sfirakis, D. A. Zarkalis, and L. L. Loukas
Pedicled Pericardial Fat Pad: A Useful Hemostatic Supplement
Ann. Thorac. Surg., March 1, 1995; 59(3): 768 - 770.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The Society of Thoracic Surgeons.